OTCMKTS:MKKGY Merck KGaA Q2 2025 Earnings Results & Report $32.62 -1.22 (-3.61%) As of 03:58 PM Eastern Merck KGaA beat analyst expectations on both earnings and revenue in its Q2 2025 results, released August 7, 2025. The company reported EPS of $0.57 versus the $0.51 consensus estimate, while revenue of $6.11 billion topped the $5.34 billion estimate by $765.90 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2025Report DateAugust 7, 2025TimeBefore Market Opens Merck KGaA EPS ResultsActual EPS$0.57Consensus EPS $0.51Beat/MissBeat by +$0.06One Year Ago EPSN/AEPS Beat Rate5 of last 8 quartersMerck KGaA Revenue ResultsActual Revenue$6.11 billionExpected Revenue$5.34 billionBeat/MissBeat by +$765.90 millionYoY Revenue GrowthN/AUpcoming EarningsMerck KGaA's next earnings date is estimated for Thursday, November 12, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Merck KGaA Q2 2025 Earnings FAQ Did Merck KGaA beat earnings estimates for Q2 2025? Merck KGaA (OTCMKTS:MKKGY) reported earnings of $0.57 per share for Q2 2025, beating the consensus estimate of $0.51. The report was announced on Thursday, August 7, 2025. What was Merck KGaA's revenue for Q2 2025? Merck KGaA reported revenue of $6.11 billion for Q2 2025, against a consensus estimate of $5.34 billion. When is Merck KGaA's next earnings date? Merck KGaA's next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Merck KGaA on the company's earnings history page. Merck KGaA Earnings HeadlinesMerck KGaA puts its shareholders' patience to the test2 hours ago | marketscreener.comMMerck KGaA (MKKGY) lags Q3 earnings estimatesNovember 12 at 12:24 PM | msn.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 12 at 1:00 AM | Weiss Ratings (Ad)Merck KGaA raises 2026 outlook as Bio-Techne deal nears completionNovember 12 at 12:24 PM | seekingalpha.comMerck KGaA Lifts Outlook Again on Life Science StrengthNovember 12 at 7:24 AM | bloomberg.comRBC Upbeat on Lonza's CDMO Deal with Merck KGaA; Forecasts UpdatedNovember 5, 2026 | marketscreener.comMSee More Merck KGaA Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Merck KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck KGaA and other key companies, straight to your email. Email Address About Merck KGaAMerck KGaA (OTCMKTS:MKKGY) is a German science and technology company headquartered in Darmstadt. Founded in 1668, it traces its origins to a pharmacy established by the Merck family and has grown into a global business serving customers in healthcare, research and industry. It is separate from the U.S.-based Merck & Co. The company operates through three main businesses. Its Healthcare division develops and markets prescription medicines, including treatments in areas such as oncology, neurology and fertility. Life Science supplies laboratory products, research tools and services, as well as materials and technologies used in pharmaceutical manufacturing. Through its Electronics division, Merck provides specialty materials and solutions for the semiconductor and display industries. The company serves customers internationally, with operations and markets spanning numerous regions around the world.View Merck KGaA ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping3 Pharmaceutical Stocks That Offer Safety and GrowthKeeping AI Cool: AAON Rides the AI Heatwave to Record GrowthPalantir’s Real Washington Risk Isn’t the Budget—It’s OversightCoreWeave's Backlog Is Surging—Can the Stock Follow?Can Constellation Energy's Contracts Power a Stock Rebound? Upcoming Earnings Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
